Table 2 UBE2C IHC level and bio-clinical parameters

From: Validation of UBE2C protein as a prognostic marker in node-positive breast cancer

Variable

UBE2C IHC<11% ( n =40)

UBE2C IHC11% ( n =52)

P -value

Age

50.4 (8.5)a

54.5 (10.4)

0.030

Histology

   

 IDC−

6

12

 

 IDC+

34

40

0.301

Histological size

   

 Raw value

25 (14)

30 (14)

0.116

 <20 mm

14

9

 

20 mm

26

43

0.088

SBR

   

 I

16

3

 

 II

18

23

 

 III

5

26

<0.001

Positive nodes

   

3

34

32

 

 >3

6

20

0.019

ER

   

 −

2

11

 

 +

38

41

0.035

PR

   

 −

7

17

 

 +

33

35

0.150

Hormonotherapy

   

 −

6

12

 

 +

34

40

0.430

IHC Ki-67

   

 <11%

25

2

 

11%

15

50

<0.001

NPI

   

 1

7

0

 

 2

27

24

 

 3

6

28

<0.001

  1. ER=oestrogen receptor; IDC=infiltrating ductal carcinoma; IHC=immunohistochemistry; NPI=Nottingham prognostic index; PR=progesterone receptor; SBR=Scarff–Bloom–Richardson.
  2. a Mean (s.d.)